BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11327217)

  • 1. Methotrexate poisoning with acute hepatorenal dysfunction.
    Goto E; Tomojiri S; Okamoto I; Tanaka K
    J Toxicol Clin Toxicol; 2001; 39(1):101-4. PubMed ID: 11327217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of methotrexate intoxication with various modalities of continuous extracorporeal therapy and glucarpidase.
    Vilay AM; Mueller BA; Haines H; Alten JA; Askenazi DJ
    Pharmacotherapy; 2010 Jan; 30(1):111. PubMed ID: 20030480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effectiveness of hemodialysis in a case of acute methotrexate poisoning].
    Gauthier E; Gimonet JF; Piedbois P; Rostoker G; Buisson C; Ben Maadi A; Samyn B; Messadi AA; Brun B; Feuilhade F
    Presse Med; 1990 Dec 22-29; 19(44):2023-5. PubMed ID: 2148614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of charcoal hemoperfusion for removal of plasma methotrexate in a patient with acute renal failure.
    Nemoto T; Imai C; Kaneko U; Takachi T; Iwabuchi H; Tanaka A; Nakamura G; Ogose A; Uchiyama M
    Pediatr Hematol Oncol; 2009; 26(7):520-5. PubMed ID: 19863208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Difficulty measuring methotrexate in a patient with high-dose methotrexate-induced nephrotoxicity.
    Al-Turkmani MR; Law T; Narla A; Kellogg MD
    Clin Chem; 2010 Dec; 56(12):1792-4. PubMed ID: 21119035
    [No Abstract]   [Full Text] [Related]  

  • 6. The utility of online haemodiafiltration in methotrexate poisoning.
    Abdelsalam MS; Althaf MM; Alfurayh O; Maghfoor I
    BMJ Case Rep; 2014 May; 2014():. PubMed ID: 24859553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe acute toxicity associated with high-dose methotrexate (MTX) therapy: use of therapeutic drug monitoring and test-dose to guide carboxypeptidase G2 rescue and MTX continuation.
    Estève MA; Devictor-Pierre B; Galy G; André N; Coze C; Lacarelle B; Bernard JL; Monjanel-Mouterde S
    Eur J Clin Pharmacol; 2007 Jan; 63(1):39-42. PubMed ID: 17115148
    [No Abstract]   [Full Text] [Related]  

  • 8. High-dose leucovorin as sole therapy for methotrexate toxicity.
    Flombaum CD; Meyers PA
    J Clin Oncol; 1999 May; 17(5):1589-94. PubMed ID: 10334548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Commentary.
    Milone MC
    Clin Chem; 2010 Dec; 56(12):1795-6. PubMed ID: 21119036
    [No Abstract]   [Full Text] [Related]  

  • 10. Commentary.
    Fox E; Balis FM
    Clin Chem; 2010 Dec; 56(12):1795. PubMed ID: 21119037
    [No Abstract]   [Full Text] [Related]  

  • 11. Continuous veno-venous hemodiafiltration in methotrexate intoxication.
    Ziółkowska H; Kisiel A; Leszczyńska B; Bilska K; Jankowska K; Kuźma-Mroczkowska E; Stelmaszczyk-Emmel A; Woźniak W; Roszkowska-Blaim M
    Med Wieku Rozwoj; 2013; 17(4):347-54. PubMed ID: 24519778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of glucarpidase (carboxypeptidase g2) in patients with acute kidney injury after high-dose methotrexate therapy.
    Widemann BC; Schwartz S; Jayaprakash N; Christensen R; Pui CH; Chauhan N; Daugherty C; King TR; Rush JE; Howard SC
    Pharmacotherapy; 2014 May; 34(5):427-39. PubMed ID: 24132809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Carboxypeptidase-G2 rescue of methotrexate intoxication].
    Grill J; Amigo-Ferreiro ME; Schoepfer C; Bonnay M; Valteau-Couanet D; Hartmann O; Vassal G
    Bull Cancer; 1998 Dec; 85(12):1066. PubMed ID: 9917559
    [No Abstract]   [Full Text] [Related]  

  • 14. Carboxypeptidase-G2 rescue in a patient with high dose methotrexate-induced nephrotoxicity.
    Widemann BC; Hetherington ML; Murphy RF; Balis FM; Adamson PC
    Cancer; 1995 Aug; 76(3):521-6. PubMed ID: 8625136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early recognition of renal toxicity of high-dose methotrexate therapy: a case report.
    Nowicki TS; Bjornard K; Kudlowitz D; Sandoval C; Jayabose S
    J Pediatr Hematol Oncol; 2008 Dec; 30(12):950-2. PubMed ID: 19131789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic interaction between high-dose methotrexate and oxacillin.
    Titier K; Lagrange F; Péhourcq F; Moore N; Molimard M
    Ther Drug Monit; 2002 Aug; 24(4):570-2. PubMed ID: 12142645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal management of methotrexate intoxication in a child with osteosarcoma.
    Peyriere H; Cociglio M; Margueritte G; Vallat C; Blayac JP; Hillaire-Buys D
    Ann Pharmacother; 2004 Mar; 38(3):422-7. PubMed ID: 14970366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous plasma resin perfusion for detoxification of methotrexate.
    Greil J; Wyss PA; Ludwig K; Bonakdar S; Scharf J; Beck JD; Ruder H
    Eur J Pediatr; 1997 Jul; 156(7):533-6. PubMed ID: 9243235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma.
    Widemann BC; Balis FM; Kempf-Bielack B; Bielack S; Pratt CB; Ferrari S; Bacci G; Craft AW; Adamson PC
    Cancer; 2004 May; 100(10):2222-32. PubMed ID: 15139068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of plasma methotrexate, neutropenia, hepatic dysfunction, nausea/vomiting and oral mucositis in children with cancer.
    Cheng KK
    Eur J Cancer Care (Engl); 2008 May; 17(3):306-11. PubMed ID: 18419635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.